A US-based biotech company planned to significantly increase clinical trial work within an expanding EU organisation.
The existing infrastructure was deemed incapable of delivering the projected number of clinical sites and subjects to global R&D.
In addition to the requirement to maintain high quality standards, the organisation also desired higher site and country productivity.
A Kinapse team completed a detailed diagnostic, including interviews with all European affiliate organisations to define issues and identify options.
A pan-EU project team analysed the data and proposed a new, scalable, organisational design.
New roles were created to maximise productivity.
The program was approved by global R&D leadership following intensive stakeholder workshops and presentations.
A resource model was created to map resource needs for the EU organisation.
A significant increase in headcount was approved to support the expansion of Europe’s R&D operations.
Implementation of the new organisational design and roles was initiated in Q2 2007.
A Program Office, set up by Kinapse during the engagement, continues to monitor and track progress of implementation and resolve ongoing issues.